Indefinite Delivery Contract SPE2DP18D0011

The Department of Health and Human Services (HHS) Office of the Assistant Secretary for Preparedness and Response (ASPR) awarded a $505.3 million single-award Indefinite Delivery Contract (IDC) to Alvogen, Inc. to deliver the antiviral drug oseltamivir phosphate to the Strategic National Stockpile. This IDC, which has an ultimate completion date of February 6, 2025, allows ASPR to issue task orders to Alvogen for the procurement and distribution of this essential medical countermeasure to...

The provided information describes an Indefinite Delivery Contract (IDC) awarded by the U.S. Department of Health and Human Services (HHS) Office of the Assistant Secretary for Preparedness and Response to Roche Laboratories Inc. The IDC, with a ceiling value of $131,245,722.23, is for the acquisition of the antiviral drug Tamiflu to support a public health emergency response to a pandemic. The contract was awarded on June 29, 2006, with a period of performance through September 1, 2010. This...

The federal contract IDV award is for the procurement of Oseltamivir Phosphate capsules and suspension by the Department of Veterans Affairs (VA) National Acquisition Center. This is a single-award, unrestricted contract with an estimated ceiling value of $10,164,262.95. The prime contractor, Exelan Pharmaceuticals Inc., is a foreign-owned, for-profit pharmaceutical company based in Boca Raton, Florida, that specializes in manufacturing, distributing, and repackaging pharmaceutical...

The Defense Logistics Agency (DLA) Troop Support Medical awarded an indefinite delivery contract to Glaxosmithkline, LLC, a foreign-owned pharmaceutical company, to provide the influenza antiviral medication zanamivir. The contract has a potential value of $4,593,750 and does not have a set-aside designation. Glaxosmithkline will deliver the pharmaceutical products from its facility in Durham, North Carolina to support DLA's medical supply and readiness programs for the Department of Defense...

The federal contract IDV is a Federal Supply Schedule (FSS) contract awarded by the Veterans Integrated Service Network 12 (VISN 12), a civilian federal agency, to Altitude Technologies Inc., doing business as Chinook Medical Gear. The contract is valued at $225,000.00 and has an ultimate completion date of January 31, 2030. The contract is for the procurement of drugs, pharmaceuticals, and hematology-related products under the FSS contract category 65 I B. Chinook Medical Gear is an 8(a)...

The Blanket Purchase Agreement was awarded as a single award by the Department of Veterans Affairs National Acquisition Center to Biocryst Pharmaceuticals, Inc. for the procurement of RAPIVAB. With a potential value of $625,000, the period of performance under the BPA extends through May 14, 2021. The BPA facilitates the delivery of RAPIVAB to treat influenza. As the leading cause of vaccine-preventable death in the United States, influenza places significant burden each year on the health...

Sanofi Pasteur Inc. was awarded a single-award indefinite delivery contract by the Department of Health and Human Services Centers for Disease Control and Prevention potentially valued at $64 million. The contract provides for the delivery of seasonal influenza vaccines to support public health programs as outlined in Section 317(j) of the Public Health Service Act. Performance will occur at the prime contractor's manufacturing facility in Swiftwater, Pennsylvania or other locations as needed...

The Defense Logistics Agency Troop Support Medical awarded Sanofi Pasteur Inc. a single award, indefinite delivery contract with a potential value of $567,566.40 to provide 850,886,1267 units of influenza virus vaccine. A firm fixed price delivery order against this contract specifies performance at Sanofi Pasteur Inc.'s Swiftwater, Pennsylvania facility from February 9, 2022 through May 13, 2022. The originating pre-solicitation sought sources capable of providing 60,000 doses of Southern...

The National Institutes of Health Clinical Center awarded Sanofi Pasteur Inc. a blanket purchase agreement to deliver influenza vaccines in support of the agency's medical programs. Under the agreement and subsequent calls issued against the Pharmaceuticals and Drugs schedule, Sanofi Pasteur will supply its influenza virus vaccine through April 2025 from manufacturing locations in Swiftwater, Pennsylvania and Bethesda, Maryland. Vaccines will be provided on a firm-fixed-price basis under task...

This Indefinite Delivery Contract (IDC) with ID 75A50118D00036 was awarded by the Office of the Assistant Secretary for Preparedness and Response (ASPR), a civilian federal agency, to Genentech Inc., a for-profit manufacturer, on September 27, 2018. The contract has a ceiling value of $611,540,628.30 and a period of performance through December 31, 2027. The contract provides funding for Genentech to conduct activities related to the antiviral drug baloxavir marboxil under a base period task...